Aspira Women's Health Inc.
AWHL· OTC
AWHLAspira Women's Health Inc.
Released Aug 12, 2021, after the close
10-Q filed Aug 12, 2021, 43 days after period end · 0000926617-21-000069
| Metric | Q2 2021 | Q2 2020 | Q2 2019 | Q2 2018 |
|---|---|---|---|---|
| Revenue | $1.80M | $746.00K | $1.14M | $708.00K |
| Net Income | -$7.07M | -$3.83M | -$4.31M | -$3.05M |
| EPS Diluted |
Aspira Women's Health Inc. · CIK 926617 · Engraved from SEC EDGAR
| -$0.06 |
| -$0.04 |
| -$0.06 |
| -$0.04 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
